Branko Brdar

1.3k total citations · 1 hit paper
36 papers, 1.0k citations indexed

About

Branko Brdar is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Branko Brdar has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Branko Brdar's work include Virus-based gene therapy research (6 papers), Nephrotoxicity and Medicinal Plants (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Branko Brdar is often cited by papers focused on Virus-based gene therapy research (6 papers), Nephrotoxicity and Medicinal Plants (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Branko Brdar collaborates with scholars based in Croatia, United States and China. Branko Brdar's co-authors include Neda Slade, Bojan Jelaković, Arthur P. Grollman, Robert J. Turesky, Frederick W. Miller, Biserka Nagy, Lin Wu, Masaaki Moriya, Zvonimir Medverec and Andrea Fernandes and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Branko Brdar

35 papers receiving 974 citations

Hit Papers

Aristolochic acid and the etiology of endemic (Balkan) ne... 2007 2026 2013 2019 2007 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Branko Brdar Croatia 11 559 364 260 225 171 36 1.0k
Viktoriya S. Sidorenko United States 16 528 0.9× 394 1.1× 229 0.9× 372 1.7× 137 0.8× 25 1.2k
Song Ling Poon Canada 13 177 0.3× 158 0.4× 72 0.3× 281 1.2× 183 1.1× 18 833
Alvin Wei Tian Ng Singapore 10 159 0.3× 126 0.3× 56 0.2× 429 1.9× 330 1.9× 15 1.0k
Arnoud Boot Netherlands 15 143 0.3× 116 0.3× 56 0.2× 384 1.7× 277 1.6× 35 906
Ivo Nnane United States 17 88 0.2× 168 0.5× 22 0.1× 359 1.6× 47 0.3× 46 1.0k
Tong Lu China 12 160 0.3× 250 0.7× 26 0.1× 483 2.1× 17 0.1× 31 861
Hitoshi Iwata Japan 15 57 0.1× 30 0.1× 18 0.1× 202 0.9× 163 1.0× 73 786
Hongfei Tong China 18 41 0.1× 86 0.2× 53 0.2× 392 1.7× 141 0.8× 36 867
Channa Keshava United States 19 50 0.1× 105 0.3× 12 0.0× 329 1.5× 209 1.2× 34 832
Maria A. Cifone United States 15 82 0.1× 41 0.1× 23 0.1× 431 1.9× 394 2.3× 20 1.0k

Countries citing papers authored by Branko Brdar

Since Specialization
Citations

This map shows the geographic impact of Branko Brdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branko Brdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branko Brdar more than expected).

Fields of papers citing papers by Branko Brdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Branko Brdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branko Brdar. The network helps show where Branko Brdar may publish in the future.

Co-authorship network of co-authors of Branko Brdar

This figure shows the co-authorship network connecting the top 25 collaborators of Branko Brdar. A scholar is included among the top collaborators of Branko Brdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Branko Brdar. Branko Brdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jelaković, Bojan, Sandra Karanović, Frederick W. Miller, et al.. (2011). Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney International. 81(6). 559–567. 161 indexed citations
2.
Moriya, Masaaki, Neda Slade, Branko Brdar, et al.. (2011). TP53 Mutational signature for aristolochic acid: an environmental carcinogen. International Journal of Cancer. 129(6). 1532–1536. 84 indexed citations
3.
Slade, Neda, et al.. (2009). p53 mutations as fingerprints for aristolochic acid – an environmental carcinogen in endemic (Balkan) nephropathy. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 663(1-2). 1–6. 38 indexed citations
4.
Grollman, Arthur P., Shinya Shibutani, Masaaki Moriya, et al.. (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proceedings of the National Academy of Sciences. 104(29). 12129–12134. 448 indexed citations breakdown →
5.
Brdar, Branko & Edward Reich. (2007). Biochemical and biological properties of 5-bromotubercidin: Differential effects on cellular DNA-directed and viral RNA-directed RNA synthesis. Bioorganic & Medicinal Chemistry. 16(3). 1481–1492. 5 indexed citations
6.
Rubelj, Ivica, et al.. (2006). Site-specific mutagenesis of the histidine precursor of diphthamide in the human elongation factor-2 gene confers resistance to diphtheria toxin. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 609(1). 34–42. 7 indexed citations
7.
Matulić, Maja & Branko Brdar. (2002). Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain. SHILAP Revista de lepidopterología. 3 indexed citations
8.
Rubelj, Ivica, Miljenko Huzak, Branko Brdar, & Olivia M. Pereira‐Smith. (2002). A single-stage mechanism controls replicative senescence through Sudden Senescence Syndrome. Biogerontology. 3(4). 213–222. 8 indexed citations
9.
Rubelj, Ivica, Miljenko Huzak, & Branko Brdar. (2000). Sudden senescence syndrome plays a major role in cell culture proliferation. Mechanisms of Ageing and Development. 112(3). 233–241. 15 indexed citations
10.
Brdar, Branko, Ivica Rubelj, & Edward Reich. (1999). DIFFERENTIAL EFFECTS OF RIBONUCLEOSIDE ANAIOGUES ON VIRUS-DIRECTED RNA SYNTHESIS. Periodicum Biologorum. 101(2). 131–136. 1 indexed citations
11.
Brdar, Branko & E. Reich. (1999). Selective Irreversible Inactivation of Replicating Mengovirus by Nucleoside Analogues: a New Form of Viral Interference. Journal of Virology. 73(8). 6444–6452. 1 indexed citations
12.
Wang, Jieyi, Branko Brdar, & E. Reich. (1995). Structure and function of microplasminogen: I. Methionine shuffling, chemical proteolysis, and proenzyme activation. Protein Science. 4(9). 1758–1767. 11 indexed citations
13.
Brdar, Branko & Maja Matulić. (1988). Induction of plasminogen activator by N-methyl-N′-nitro-N-nitrosoguanidine in mer+ and mer human tumour cell strains. Carcinogenesis. 9(12). 2191–2195. 5 indexed citations
14.
Brdar, Branko. (1986). Induction of plasminogen activator by alkylating agents in a repair defective human glioblastoma cell strain.. PubMed. 46(5). 2282–4. 11 indexed citations
15.
Kobe, J., et al.. (1982). Synthesis and antiviral activities of 2-substituted azino-3-(D-arabinofuranosyl)-5-carboxymethylene-thiazolidine-4-ones.. PubMed. 37(11). 764–80. 1 indexed citations
16.
Brdar, Branko, et al.. (1980). Inhibition of viral RNA synthesis by 1-methyl-1-nitrosourea. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 606(2). 285–291.
17.
Gamulin, Vera, et al.. (1979). Dimethyl-10,12-benz(a)acridine: Evidence for differential effects on the synthesis of RNA of mammalian or avian fibroblasts and some RNA viruses. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 562(1). 139–148. 1 indexed citations
18.
Nagy, Biserka, et al.. (1977). Fibrinolysis associated with human neoplasia: Production of plasminogen activator by human tumours. International Journal of Cancer. 19(5). 614–620. 103 indexed citations
19.
Brdar, Branko, Daniel B. Rifkin, & E. Reich. (1972). Specificity of Rous sarcoma virus synthesis. FEBS Letters. 24(3). 347–350. 5 indexed citations
20.
Brdar, Branko & P. Fromageot. (1970). Inhibition of viral RNA synthesis by levallorphan. FEBS Letters. 6(3). 190–192. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026